Ingenia Therapeutics Inc. — Form D
Ingenia Therapeutics Inc. of WATERTOWN, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-12-13. The offering totals $5.0M, of which $100K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2019-12-13
- Form: D
- Accession: 0001796831-19-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $100K
- Remaining: $4.9M
- Investors: 1
- Date of first sale: 2019-11-29
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-355514
Issuer
- Name: Ingenia Therapeutics Inc.
- CIK: 0001796831
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 134 COOLIDGE AVENUE, WATERTOWN, MA, 02472
- Phone: (781) 491-9005
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Sang Gyun Kim | Director | Watertown, MA |
| Eric Furfine | Director | Watertown, MA |
| Joo Hee Kwak | Director | Watertown, MA |
| Sangyeul Han | Director | Watertown, MA |
| Sangyeul Han | Executive Officer | Watertown, MA |
| Kwang Ho Cheong | Director | Watertown, MA |
| Sung Jae Kim | Director | Watertown, MA |
| Heewon Park | Director | Watertown, MA |
| Minji Kim | Director | CAMBRIDGE, MA |
| Minji Kim | Executive Officer | CAMBRIDGE, MA |
Other filings by this issuer (3)
More